Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03733015
Other study ID # 54271916.8.0000.0068
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 10, 2018
Est. completion date December 15, 2018

Study information

Verified date November 2018
Source Aalborg University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main purpose of the study is to assess whether repeated sessions of repetitive trancranial magnetic stimulation (rTMS) applied on left dorsolateral prefrontal cortex main boost the pain thresholds.


Description:

Pain is the largest health-related burden on society and, despite many decades of pain research, there are still few effective treatments. Since pain experience is a construct of the central nervous system (CNS), chronic pain has been recently thought to be a CNS disorder.

Repetitive transcranial magnetic stimulation (rTMS) is a safe, non-invasive technique for cerebral cortex stimulation and the clinical applications of which have expanded considerably in recent years. Recent studies have been shown that 'classical' rTMS to different cortical areas temporary reduce chronic and acute pain, suggesting that rTMS may ´have some clinical application in future management of chronic pain. However, new rTMS paradigms involving theta burst stimulation (TBS) have recently been described with the major clinical advantage to be much shorter than 'classical' rTMS. The investigators hypothesize that cTBS would yield analgesic effects similar to or, possibly, even stronger than those produced by 'classical' rTMS. The investigators will carry out a sham-controlled, randomized, double-blind, crossover study in healthy volunteers, to compare the analgesic effects of two rTMS protocols over dorsolateral prefrontal cortex: classical high-frequency rTMS (10 Hz), and TBS. As rTMS-induced analgesia may be dependent on changes in pain modulatory systems, the investigators will analyze the effects of the stimulation on conditioned pain modulation (CPM). More specifically, the investigators will compare the effects of multiple sessions of rTMS on the inhibition of a test experimental stimulus induced by heterotopic noxious stimuli, to assess possible changes in diffuse noxious inhibitory controls.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date December 15, 2018
Est. primary completion date December 15, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Healthy volunteers

Exclusion Criteria:

- Major medical conditions

Study Design


Related Conditions & MeSH terms


Intervention

Device:
repetitive transcranial magnetic stimulation
Repetitive transcranial Magnetic Stimulation (rTMS) can be used to temporary modify the brain activity.

Locations

Country Name City State
Denmark Enrico De Martino Aalborg Nordjylland
Denmark Enrico De Martino Aalborg

Sponsors (1)

Lead Sponsor Collaborator
Aalborg University

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pressure pain thresholds (PPT) Pressure will be applied at a rate of 30 kPa/s perpendicularly to the surface of the skin using a handheld algometer (1-cm2 probe; Somedic, Hörby, Sweden). Three readings at the pressure pain threshold (PPT) will be made at 1-minute intervals, at four sites; i) right elbow, ii) left elbow, iii) right leg and iv) left leg. The data will be reported in kPa. The study comprises two interventions of four experimental sessions on consecutive days (Day-1 to Day-4). Changes from Day-1 at Day-4 will be investigated.
Primary Cold pain thresholds, heat pain thresholds and supra-thresholds painful stimuli The temperature of the thermode is slowly decreased or increased to the maximum tolerable levels. The participant will click a button as soon as the tolerable level has been reached, which will bring the temperature back to baseline 32 degrees Celsius. Thresholds are determined by raising or dropping the temperature slowly from baseline skin temperature until the participant reports feeling of pain. The experimenter will then determine the temperature that is consistently rated as moderately painful by applying a temperature above the threshold level and asking the participant to rate the pain from 0 (no pain) to 10 (most intense pain imaginable). The study comprises two interventions of four experimental sessions on consecutive days (Day-1 to Day-4). Changes from Day-1 at Day-4 will be investigated.
Primary Condition pain modulation (supra-thresholds painful stimuli ): visual analogue scale (VAS: 0-100mm) First, the volunteers will immerse the left hand in a bucket with water and ice at 4° C for around 45-60 seconds to reach a VAS pain of 60—70/100mm. Immediately after, supra-thresholds painful stimuli over the right leg will be repeated in a randomized order. The supra-thresholds painful stimuli will be reported in a VAS scale (from 0 to 10). The study comprises two interventions of four experimental sessions on consecutive days (Day-1 to Day-4). Changes from Day-1 at Day-4 will be investigated.
Primary Condition pain modulation (pressure pain thresholds): visual analogue scale (VAS: 0-100mm) First, the volunteers will immerse the left hand in a bucket with water and ice at 4° C for around 45-60 seconds to reach a VAS pain of 60—70/100mm. Immediately after, pressure pain thresholds over the right leg will be repeated. The pressure pain thresholds will be reported in kPa. The study comprises two interventions of four experimental sessions on consecutive days (Day-1 to Day-4). Changes from Day-1 at Day-4 will be investigated.
See also
  Status Clinical Trial Phase
Completed NCT02901561 - Comparison Between 2 Doses of Misoprostol Before Intrauterine Device Phase 2/Phase 3
Completed NCT02905045 - Efficacy of Ketoprofen Before Hysterosalpingography Phase 3
Completed NCT02905058 - Efficacy of Ketoprofen Before Intrauterine Device Insertion Phase 3
Recruiting NCT00773760 - MOR and COMT SNP Polymorphism and Pain N/A
Completed NCT02943135 - Lidocaine In-situ Gel Before Intrauterine Device Insertion Phase 3
Completed NCT04473508 - Erectus Nerve Block for Lumbar Spine Surgery Phase 3
Completed NCT02969902 - Buzzy Distraction During Venipuncture N/A
Enrolling by invitation NCT03184649 - Ibuprofen, Paracetamol Versus Placebo on Pain During Local Anesthetic Injection (RCT) Phase 1/Phase 2
Completed NCT02614391 - Tablet Distraction for Pain Control During Venipuncture Phase 3
Recruiting NCT00768014 - fMRI Measurements on Pain Relief Methods in First Stage Labor Pain N/A
Completed NCT04586712 - Efficacy of a Controlled Short-term Trial of Cannabidiol (CBD) Ingestion on Reducing Symptomatic Response and Facilitating Recovery After Induced Muscle Injury Phase 2
Not yet recruiting NCT04781777 - Effect of Ultrasonographic Guided Insulin Injection With Dexamethasone and Local Anesthetic Mixture in Diabetic Patients With Mild to Moderate Carpal Tunnel . N/A
Recruiting NCT06456177 - Nociception Monitoring During Epidural Analgesia
Recruiting NCT00914498 - The Effect of Pre-incisional Local Xylocaine Injection on Post Operative Pain and Scar Formation After Cesarean Section N/A
Completed NCT00638274 - Comparison of Loss of Resistance Techniques Phase 2
Recruiting NCT04656821 - Erector Spinae Block Versus Thoracic Paravertebral Block for Acute Thoracic Herpes Zoster Phase 4
Withdrawn NCT01263652 - Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine Patients N/A
Completed NCT01925469 - Benzocaine Versus Placebo Spray for Pain Relief at Hysterosalpingogram Phase 4
Completed NCT00580489 - Lifeflight: Fentanyl Versus Morphine N/A
Completed NCT03263884 - Repetitive Transcranial Magnetic Stimulation and the Development of Ongoing Muscle Pain N/A